Skip to content
Open access · CC-BY via OpenAlex

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases

Matilde Contardo, Roberta De Gioia, Delia Gagliardi, Giacomo P. Comi, Linda Ottoboni, Monica Nizzardo, Stefania Paola Corti

Biomedicines · 2022 · ▲ 14 citations

Abstract

In vivo cell reprogramming of glial cells offers a promising way to generate new neurons in the adult mammalian nervous system. This approach might compensate for neuronal loss occurring in neurological disorders, but clinically viable tools are needed to advance this strategy from bench to bedside. Recently published work has described the successful neuronal conversion of glial cells through the repression of a single gene, polypyrimidine tract-binding protein 1 (Ptbp1), which encodes a key RNA-binding protein. Newly converted neurons not only express correct markers but they also functionally integrate into endogenous brain circuits and modify disease symptoms in in vivo models of neurodegenerative diseases. However, doubts about the nature of “converted” neurons, in particular in vivo, have been raised, based on concerns about tracking reporter genes in converted cells. More robust lineage tracing is needed to draw definitive conclusions about the reliability of this strategy. In vivo reprogramming and the possibility of implementing it with approaches that could be translated into the clinic with antisense oligonucleotides targeting a single gene like Ptbp1 are hot topics. They warrant further investigation with stringent methods and criteria of evaluation for the ultimate treatment of neurological diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/biomedicines10020399
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Contardo, M., Gioia, R.D., Gagliardi, D., Comi, G.P., Ottoboni, L., Nizzardo, M., &amp; Corti, S.P. (2022). Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines10020399
Vancouver
Contardo M, Gioia RD, Gagliardi D, Comi GP, Ottoboni L, Nizzardo M, et al. Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. Biomedicines. 2022. doi:10.3390/biomedicines10020399.
BibTeX
@article{matilde2022Target, title = {Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases}, author = {Matilde Contardo and Roberta De Gioia and Delia Gagliardi and Giacomo P. Comi and Linda Ottoboni and Monica Nizzardo and Stefania Paola Corti}, journal = {Biomedicines}, year = {2022}, doi = {10.3390/biomedicines10020399}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings